StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences cash

Cash and short-term investments held at the end of each period.

Panacea Life Sciences's cash was $117.15K at Mar 31, 2024. For fiscal 2023 it was $115.86K, down 89.6% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $3.81M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2023Dec 31, 2023$115.86K-89.6%
FY2022Dec 31, 2022$1.11M-70.8%
FY2021Dec 31, 2021$3.81M+29.7%
FY2020Dec 31, 2020$2.94M+15862.1%
FY2019Dec 31, 2019$18.41K+839.0%
FY2018Dec 31, 2018$1.96K-98.8%
FY2017Dec 31, 2017$161.22K-84.7%
FY2016Dec 31, 2016$1.06M–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$42.50K+19.7%
FY2013Dec 31, 2013$35.50K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$117.15K-88.3%
Q4 FY2023Dec 31, 2023$115.86K-89.6%
Q3 FY2023Sep 30, 2023$79.92K-93.1%
Q2 FY2023Jun 30, 2023$468.58K-82.0%
Q1 FY2023Mar 31, 2023$998.34K-65.6%
Q4 FY2022Dec 31, 2022$1.11M-70.8%
Q3 FY2022Sep 30, 2022$1.15M-68.4%
Q2 FY2022Jun 30, 2022$2.60M-57.6%
Q1 FY2022Mar 31, 2022$2.90M+14618.7%
Q4 FY2021Dec 31, 2021$3.81M+29.7%
Q3 FY2021Sep 30, 2021$3.65M+6074.9%
Q2 FY2021Jun 30, 2021$6.14M+1953.8%
Q1 FY2021Mar 31, 2021$19.72K+106.7%
Q4 FY2020Dec 31, 2020$2.94M+15862.1%
Q3 FY2020Sep 30, 2020$59.05K+938.6%
Q2 FY2020Jun 30, 2020$298.75K-55.1%
Q1 FY2020Mar 31, 2020$9.54K-99.2%
Q4 FY2019Dec 31, 2019$18.41K+839.0%
Q3 FY2019Sep 30, 2019$5.69K+340.4%
Q2 FY2019Jun 30, 2019$664.65K+1130.6%
Q1 FY2019Mar 31, 2019$1.17M+2912.5%
Q4 FY2018Dec 31, 2018$1.96K-98.8%
Q3 FY2018Sep 30, 2018$1.29K-96.1%
Q2 FY2018Jun 30, 2018$54.01K+198.3%
Q1 FY2018Mar 31, 2018$38.94K-86.9%
Q4 FY2017Dec 31, 2017$161.22K-84.7%
Q3 FY2017Sep 30, 2017$32.97K-4.4%
Q2 FY2017Jun 30, 2017$18.10K-53.3%
Q1 FY2017Mar 31, 2017$296.91K+30.7%
Q4 FY2016Dec 31, 2016$1.06M–
Q3 FY2016Sep 30, 2016$34.49K+194.2%
Q2 FY2016Jun 30, 2016$38.78K+2.3%
Q1 FY2016Mar 31, 2016$227.09K+434.4%
Q4 FY2015Dec 31, 2015$0-100.0%
Q3 FY2015Sep 30, 2015$11.73K-88.4%
Q1 FY2015Mar 31, 2015$37.92K+6.8%
Q4 FY2014Dec 31, 2014$42.50K–
Q3 FY2014Sep 30, 2014$86.19K–
Q2 FY2014Jun 30, 2014$101.33K–
Q4 FY2013Dec 31, 2013$35.50K–

More Panacea Life Sciences figures

See a number that looks wrong?